Intravitreal injection of anti-VEGF agents in wet age-related macular degeneration: a 5-year retrospective study

Journal Title: Eye Science (Yanke Xuebao) - Year 2022, Vol 37, Issue 7

Abstract

[Objective:] To investigate the efficacy of anti-VEGF injection in the treatment of wet age-related macular degeneration (wAMD) for 5 years. [Methods:] A total of 84 patients (103 eyes) wAMD diagnosed in Department of Ophthalmology in Beijing Hospital from 2011 to 2021 were analyzed retrospectively. 3 + PRN regimen was applied for anti-VEGF treatment. The changes of best corrected visual acuity (BCVA), the number of intravitreal injections and the number of follow-up visits, and the anatomical changes of the lesions in the past 5 years were collected. [Results:] The average BCVA after 5 years was 38.1 letters, indicating a decrease of 9.4 letters comparing to baseline, which was statistically significant (P<0.001). 23.3% of the eyes could maintain the baseline BCVA after 5 years. The average injection times within 5 years was 13.8, and the injection was concentrated in the first year, with an average of 4.3. The average number of follow-up visits within 5 years was 24.3, and only 34.0% of the affected eyes could keep the follow-up interval ≤3 months. After 5 years, 68.0% of the eyes developed fibrous scar, 27.2% developed geographic atrophy, and 69.0% (71/103) had consistent pigment epithelial detachment. Factors significantly affect BCVA include: age, baseline BCVA, initial treatment, follow-up time, injection times, central retinal thickness, geographic atrophy and so on. [Conclusion:] Most patients can maintain vision within the first year after anti-VEGF treatment, but the efficacy is poor for more than 5 years. Early diagnosis and treatment, and increased injection frequency may be the research direction for improving prognosis in the future.

Authors and Affiliations

Jingjing XU, Jianing WANG, Yingyi LU, Hong DAI

Keywords

Related Articles

A case of hyperopic drift after cataract surgery in a patient with previous laser in situ keratomileusis

It is reported in this article that a 40-year-old female patient presented with "progressive blurred vision of both eyes for 3 months". The patient underwent bilateral laser in situ keratomileusis (LASIK) because of high...

Differential effects of primary disease and corneal vascularisation on corneal transplant rejection and survival

[Objective:] To investigate the relative risk of pretransplant corneal vascularisation on rate of rejection and graft failure within 5 years of surgery when categorised by indication for transplantation. [Methods:] We an...

Association of bone destruction, nerve invasion and prognosis of lacrimal gland adenoid cystic carcinoma with different histological types and grades

[Objective:] To investigate the differences in bone destruction, nerve invasion, and prognosis of lacrimal gland adenoid cystic carcinoma (LGACC) among different histologic types and grades. [Methods:] A retrospective an...

Research progress on dry eye associated with chronic graft-versus-host disease

Chronic graft-versus-host disease (cGVHD) is one of the most devastating complications following bone marrow transplantation. GVHD develops in 10–80% of patients after hematopoietic stem cell transplantation (HSCT). The...

Summary of the best evidence on standardized ocular medication management among open-angle glaucoma patients

[Objective:] To retrieve and summarize the best evidence on standardized ocular medication management among open-angle glaucoma patients. [Methods:] With evidence-based nursing method, practical problems were identified....

Download PDF file
  • EP ID EP763695
  • DOI 10.3978/j.issn.1000-4432.2022.06.07
  • Views 16
  • Downloads 0

How To Cite

Jingjing XU, Jianing WANG, Yingyi LU, Hong DAI (2022). Intravitreal injection of anti-VEGF agents in wet age-related macular degeneration: a 5-year retrospective study. Eye Science (Yanke Xuebao), 37(7), -. https://www.europub.co.uk/articles/-A-763695